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Abstract
Purpose: The purpose of this research is to quantify the cost burden, care times and the impact on the
quality of life (QoL) of informal caring relatives caring for patients with wet age-related macular degeneration
(wet AMD). Moreover we investigated the impact of care times on the QoL.
Methods: Through a specifically designed questionnaire, 150 caring relatives were interviewed retrospectively
on all accrued financial costs, caring times incurred and the current QoL, assessed by a Visual Analogue Scale
for happiness (VAS).
Results: The caring time incurred was on average 6.4 ± 8.5 (mean +/- SD) hours per week. The QoL was on
average rated at 6.7 ± 1.9 on a ten point scale. Financial strain was incurred by the direct non-medical costs
of on average € 405 ± 1104 and the direct medical costs of on average € 134 ± 340 per year. Indirect costs
were stated by two caregivers as amounting to € 2400 and € 6000 net income loss per year respectively.
Caregivers of privately insured patients with wet AMD carried a financial cost burden which was up to six
times higher than caregivers of patients who were on state insurance while showing the same visual acuity.
Conclusion: The evaluation shows that caregivers of privately insured patients with wet AMD have higher
costs than caregivers of patients with state insurance coverage. This burden seems to be a factor to be
considered independently since it does not appear to have any relation to patients AMD acuity.
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Background
It is well known that by 80 years old, more than 80 % of
the main causes of blindness are due to age-related condi-
tions such as age-related macular degeneration (AMD),
cataract and glaucoma [1]. Due to our increasing elderly
population, resource allocation for the treatment and
monitoring of these potentially blinding conditions has
been expanded. Epidemiological studies in AMD were
able to provide information on the prevalence of the con-
dition and demonstrate a six-fold risk of developing AMD
at the age of 70–79, growing to 25-fold in persons over 80
in comparison to the 55–69 age group [2]. The treatment
results have changed from stabilising vision using laser
photocoagulation or photodynamic therapy to improving
vision using intravitreal injections with anti-vascular endo-
thelial growth factor (anti-VEGF) [3]. AMD represents a
major public health priority for global health systems, but
there are only very few studies, such as the study of
Bandello et al., Javitt et al. or Pauleikoff et al., that
assess the economic burden.
AMD has a profound effect on patients’ QoL, especially
once the disease has progressed to its late stages as is the
case with wet AMD [4–7]. As vision loss causes a higher
need for care, an important aspect worth exploring is how
much the quality of life of caregivers is affected. The fact
that patients with degrading vision can, to a certain extent,
overcome functional difficulties – for example by using
magnifying glasses, screen-projection devices or other
low-vision aids and devices – makes it interesting to figure
out if the caregiver cost burden correlates with the vi-
sion loss of the affected patient. The burden on patients
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themselves has already been subject to plenty of research.
They have shown that medical and non-medical costs of
patients with wet AMD are incurred on a considerable
scale [8, 9]. Regarding the caregiving relatives, it is known
that the visual impairment of patients contributes to a
35.4 % higher risk of depression in said relatives. Further-
more, the ability to deal with social problems and the
overall life satisfaction is reduced in relatives tasked with
caring for the patients [10]. The increased costs of patients
affected by wet AMD stands in direct correlation with
their remaining visual acuity [11, 12]. Although it is
acknowledged that the role of informal caregivers is
important, little is known about the consequences of
giving care to patients with wet AMD. Considering
these findings and against the background of the in-
creasing costs for the medical treatment, knowing to
what extent caregivers are financially burdened and
which strains are placed upon their QoL is very valu-
able. The primary target of the study was to quantify
and analyse the burden placed on the caregiver regard-
ing incurred financial resources, invested time and the
QoL. Subsequently, tests were carried out to determine
whether the caregiver burden was associated with
 the visual acuity of the patient,
 the caregiver gender,
 the intensity of caregiving.
Methods
For this study, 150 caring relatives of 150 patients with
wet AMD were recruited over the course of 18 months,
from 1 January 2013 to 31 July 2014, at the Department of
Ophthalmology, RWTH Aachen University. The inter-
views were all conducted at the Department by the same
research assistant under GCP-compliant conditions, since
the patients and the caregivers were informed by an infor-
mation sheet and have signed the declaration of consent.
Almost every patient and caregiver was interested in par-
ticipating in this study. The study was approved by the
Ethics Committee of the University Hospital Aachen. The
patients were recruited regardless of the patient’s age and
visual acuity. Patient inclusion criteria were a confirmed
diagnosis of wet AMD and permanent residence in the
Federal Republic of Germany. Patients were excluded if
they had other diseases requiring care by professionals or
caregivers. Inclusion criteria for the caregivers were an
existing family relationship with the patient as well as the
ability to communicate in German and a minimum age of
18 years. In this study, all potential costs arising on the
relatives’ side were structured using health economic clas-
sification methods subdivided into three groups of costs;
direct costs, indirect and intangible costs. The caregivers
were asked once about their costs during different time
periods (last 3 weeks, last 3 month, last year and last 3
years), which were calculated to represent the caregiver
cost of 1 year.
Questionnaire
The questionnaire used in this study is composed of 16
pages and was completed independently by the caregivers
in approximately 30 min.
First of all, questions were asked about the intensity of
the care given to the patients. Here, the average hours of
care per week and care characteristics were noted. Then
inquiries about the caregivers’ QoL were made using the
Visual Analogue Scale (VAS). The VAS had already prov-
een to be easily applicable and understandable. It facili-
tates surveying the impact on caregivers’ QoL [13]. Using
the VAS, the caregivers could indicate their QoL on a
scale from 0 (totally unhappy) to 10 (perfectly happy). In
addition to the VAS, the QoL was measured using the
Caregiver Reaction Assessment-Questionnaire (CRA).
The 24 questions of the CRA measured the caregivers
self-esteem (7 questions), impact on schedule (5 ques-
tions), lack of family support (5 questions), impact on
finances (3 questions) and impact on health (4 questions)
[14]. A descriptive analysis and a principal component
analysis of the CRA can be viewed in another publication
by the same authors [15]. In the questionnaire, the CRA
was followed by data on a wide variety of doctors’ visits –
for which the patients had to be accompanied by the care-
givers; the data included the number of visits, the dis-
tances covered and the time spent. Further costs – such
as travel costs, parking fees, costs for medication and vis-
ual aids, individual health services and co-payments –
were also captured, providing that these costs were not
reimbursed and were paid for by the caregiver, since the
cost calculation was made from the perspective of the
caregiver. Furthermore, the time spent on daily activities
by caregivers (household chores, leisure activities and
office work) were identified and quantified. Finally, socio-
demographic data of the caregivers – such as age, family
relationship to the patient, employment status, household
income, living situation and marital status – were re-
corded. Patient data – such as visual acuity, diagnosis,
previous therapies and visual co-morbidities – were also
transferred from the patient records to the questionnaire.
The resource consumption (e.g. time caring hours per
week) was transferred to the calculated costs. For this
purpose in particular the coefficient of determination was
used to indicate the proportion of the variance in the
dependent variable that is predictable from the independ-
ent variable. The intangible costs were calculated through
the given values on the VAS.
Statistical evaluation
All analyses were conducted using SAS 9.2 (SAS Institute
Inc., Cary, North Carolina) with a significance level of 5 %.
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Categorical data are presented by frequencies and percent-
ages. Continuous variables are presented as mean values
± standard deviation (SD). For the statistical analysis of
the data, the Kruskal-Wallis-test, Wilcoxon-test, t-test,
linear regression, chi-square test and multivariate
ANCOVA were used as appropriate.
Results
Participants
150 caregivers of 150 patients with wet AMD were
included in the study. The missing values amounted to
3.3 %. The caregivers consisted of a group of 92 women
(61 %) and 58 men (39 %). The average age was 60 years
and was distributed between 18 and 83 years. 49 % of
caregivers were younger than 60 years. Most caregivers
were spouses (47 %) or children (39 %) of the patients.
The patients consisted of a group of 79 women (53 %) and
71 men (47 %). The patient age was, on average, 77 years.
The patients’ visual acuity of the better eye was divided
into three groups: (1) 58.6 % had a visual acuity of >0.3,
(2) 18 % had a visual acuity between ≤ 0.3 and >0.1, and
(3) 35.3 % had a visual acuity of ≤ 0.1. The division into
these groups was made after consultation with the oph-
thalmologists of the eye clinic. Most patients (81 %) were
insured by the state; the remaining patients (19 %) were
privately insured. An overview of the socio-demographic
data can be found in Table 1.
Caring time
On average, the caring time amounted to 6.4 ± 8.5 h per
week with a minimum of 0.25 and a maximum of 55 h per
week. In a comparison between male and female care-
givers, it was shown that female caregivers spend more
time on care with 6.86 h per week ± 9.37, compared to the
male caregivers with an average of 5.59 h per week ± 6.89.
In addition, the relatives reported the caregiving time for
various activities in the day-to-day life of the patient. Most
of the time was spent on household assistance (4.2 h),
leisure activities (1.1 h) and office work (0.5 h) on average
per week. The caring hours per week depended on the
visual acuity of the patient. In Fig. 1 the significant inter-
dependence between the absolute number of caring hours
per week and the visual acuity (Kruskal-Wallis p-value
<0.01) is shown. A visual acuity of >0.3 caused on average
4.3 ± 4.4, a visual acuity of ≤0.3 - >0.1 caused on average
5.6 ± 5.9 and a visual acuity of ≤0.1 caused on average
11.9 ± 14.2 caring hours per week. This is demonstrated in
the boxplots in Fig. 1.
The caregivers were also asked to note the time they
spent accompanying the patient to medical treatments.
The time spent accompanying the patient to appoint-
ments for intravitreal injections took an average of 14.5 h
a year. Since 35 % of the caregivers were employed, the
leave these caregivers subsequently had to take in order to
care for the patient amounted to an average of 3 complete
days a year. The specific caring activities and caring times
of the caregivers are shown in Table 2.
The care activities were different with regard to the gen-
der of the caregiver. The results are shown in Fig. 2.
Financial strain
The most financial strain was brought on by the direct
non-medical costs (travel costs, costs for housekeepers,
acquisition costs and modifications). For this purpose, the
caregivers spent an average of € 405 ± € 1103 and had a
minimum value of € 0 and a maximum of € 7356 per year.
The direct medical costs (medical treatment and medica-
tion) amounted to an average of € 134 ± € 340 and had a
minimum value of € 0 and a maximum value of € 2529 a
year. Two caregivers indicated indirect costs due to lost
productivity in the workplace. They had to reduce their
hours of employment. It was stated by one caregiver that
they had a loss of net income of € 2400 per year. The
other caregiver stated a loss of € 6000 net income per year.
In the total sample, these results have a mean of € 56 ± €
526 per year. Spouses had more total direct costs per year
than children (Wilcoxon p = 0.013). On average, the costs
amounted to € 689 for spouses and € 461 for children.
Table 1 Socio-demographic data of patients and caregivers
Variable n (%)
Patients
Age (years) (Mean 77.17) (SD 7.72)
Male 71 47
Female 79 53
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The three different types of costs were very unevenly dis-
tributed in the total sample, which can be seen in Fig. 3.
Both the direct medical costs as well as the direct
non-medical costs of the caregivers were directly related
and both increased significantly by the weekly amount
of hours needed to care for the patients. One hour more
per week caused € 23 more direct medical costs per year
(R2 = 0.34) and € 62 more non-medical costs (R2 = 0.23)
per year for the relative. However, there was no direct
significant relationship between any of the three visual
acuities and the rising costs for the caregivers. Neverthe-
less, as a worse visual acuity caused a higher caring inten-
sity in hours per week, the financial strain was indirectly
associated with the visual acuity. A correlation between
the caregiver gender and the cost burden or loss of QoL
could not be found. Furthermore, to test multivariate ef-
fects on the total direct costs, a multivariate ANCOVA
was performed with the total direct costs as the dependent
Fig. 1 Three boxplots show the significant interdependence between the absolute number of caring hours per week and the visual acuity
(Kruskal-Wallis p-value <0.01). A visual acuity of >0.3 caused on average 4.3 ± 4.4, a visual acuity of ≤0.3 - >0.1 caused on average 5.6 ± 5.9 and a
visual acuity of ≤0.1 caused on average 11.9 ± 14.2 caring hours per week
Table 2 Caring activities and caring times











Mean SD Mean SD Mean SD Mean SD
Average number of outpatient visits per year (times/year) 9.4 9.7 7.7 8.4 10.3 8.5 13.6 13.0
Average number of accompaniments for intravitreal injections (times/year) 3.3 3.5 3.3 3.8 2.9 2.7 3.7 3.4
Average time spent for each outpatient (hours/visit) 3.7 2.7 3.7 2.0 3.4 2.2 3.6 2.3
Average time spending for accompanying for intravitreal injections; (hours/visit) 3.6 2.1 3.7 2.0 3.4 2.2 3.6 2.3
Average time for household assistance (hours/week) 4.2 12.9 1.4 3.4 9.3 27.0 8.1 11.0
Average time per week for leisure activities (hours/week) 1.2 2.9 0.6 1.7 1.5 3.3 2.4 4.5
Average time per week for office work (hours/week) 0.5 1.2 0.4 0.9 0.4 0.7 1.0 1.9
It becomes clear that, especially with a deterioration of a visual acuity from ≤0.3 - >0.1 to a visual acuity of ≤0.1, the caregivers had on average an increasing care
intensity in the different caring activities
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Fig. 2 Stacked bar chart with the different mentioned abundances of caring activities. The organization of everyday-life, patient care and participation
in discussions with the doctor as well as the decision concerning the patient’s treatment were included in the questionnaire. The questions were
answered based on a 5-point Likert scale (1 = never, 2 = seldom, 3 = occasionally, 4 = often, 5 = always). The question about the caregiving concerning
the everyday-life of the patient because of the wet AMD was answered mostly with “never”. However, of the total answers marked ‘always’, 88.8 % was
a female caregiver and 11.1 % was male. For the answers marked ‘often’, 77.27 % was female and 22.73 % was male. Concerning the everyday-life
caregiving of the patient, a significant gender difference could be shown by a chi-squared test (p = 0.02). When it comes to the organization of the
treatment of wet AMD, 37.3 % indicated that the organization of treatment had ‘seldom’ taken place. However, of the 30.6 % of the total sample
that reported that they ‘always’ organized the treatment, 80.4 % were women and 19.5 % were men. The participation of the caregiver at doctors
appointments concerning the wet AMD was also requested. The caregivers answered in 45.3 % of the cases that they were ‘always’ involved in the
appointments. This ‘always’ was given by 74.6 % of female caregivers and by 25.4 % of male caregivers. Also, the response option ‘often’ was given by
68.7 % of women and by 31.2 % of men. Here a significant gender difference could be shown by a chi-squared test (p = 0.03)
Fig. 3 Three different boxplots of the absolute number of the direct medical, direct non-medical and indirect costs of the caregivers. The costs
show a skew in the distribution. The most financial strain was brought on by the direct non-medical costs on average € 405 ± € 1103. The direct
medical costs amounted to an average of € 134 ± € 340 and two caregivers had indirect costs, namely a loss of net income of € 2400 per year
and a loss of € 6000 net income per year. In the total sample, these results had a mean of € 56 ± € 526 per year
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variable. Here, the higher caring hours per week, a higher
patient age and the fact that the patients were privately
insured had a significant influence on the increasing costs,
while the caregiver gender, visual acuity of the patient and
the caregiver age did not affect the total direct costs
shown in Table 3.
The analysis showed that the cost burden of the care-
givers was associated with whether the patient is privately
or state health insured. The caregivers of privately insured
patients had significantly higher total direct costs than the
others (Wilcoxon p = 0.04). On average, the caregivers of
state insured patients bore total direct costs of € 385 and
caregivers of privately insured patients an average total of €
1207 per year. Also the medical costs of caregivers of pri-
vately insured patients were higher (Wilcoxon p = 0.03).
However, by analysing the different visual acuity of the pa-
tients, it was clear that there was no dependence concern-
ing the visual acuity. Caregivers of privately insured
patients with the same visual acuity of >0.3 bore double the
costs. On average, caregivers of privately insured patients
bore costs of € 651 a year, whereas those of state insured
patients bore an average of € 324 a year. Caregivers of pa-
tients with the same visual acuity of ≤ 0.1 paid an average of
€ 4024 a year for privately insured patients and an average
of € 672 a year for state insured patients, i.e. an almost six
times greater cost burden. These increased caregiver costs
of privately insured patients could neither be explained by
the patients’ visual acuity nor by a higher caregiver income.
Also, there was no association with more caring hours per
week for caregivers of privately insured patients that could
explain the higher costs. Particularly since the Median of
the direct medical costs, was much higher for caregivers of
privately insured patients. The different caregiver costs are
shown in the Appendix 1 in Fig. 4 and Fig. 5. The cost
overview is shown in Table 4.
By splitting the costs into the three different visual acu-
ities one observes that the third group incurs the highest
cost burden for the caregivers. However the increase in
burden is not continuous as shown in the Appendix 2 in
Table 5.
Quality of life
The QoL of the caregivers, which has been captured by
the VAS, was given on a scale from 0 “totally unhappy” to
10 “perfectly happy”. Here, the mean value was 6.73 ±
1.90. The minimum value was 2 and the maximum value
10. Male caregivers had an average value of 6.93 ± 1.95
and female caregivers an average value of 6.61 ± 1.87.
In a multivariate ANCOVA with the dependent variable
of the QoL through the VAS, several variables were tested
for their influence on the caregivers’ QoL, which can be
seen in Table 3. Here, the caring hours per week were the
only variable that had a significant negative impact on the
caregivers’ QoL. Increased hours of care per week meant
the QoL decreased (p < 0.001). The gender of the care-
giver, the visual acuity of the patient, the insurance of the
patients, the patient age and the caregiver age had no sig-
nificant effect on the QoL of the caregiver.
Discussion
Rising costs in the healthcare system mean that a balance
needs to be struck between the medical options, their
financial sustainability, as well as quality and equity. Con-
sequently, scientific methods in health economics support
decision-making in healthcare. The aim is to establish a
relationship between the added benefit of an intervention
and the scarcity of resources incurred. As wet AMD is
mainly treated by very expensive intravitreal injections
(VEGF inhibitors), the question is: to what extent are the
persons concerned actually burdened? For these reasons,
the detection of strain on those affected and their care-
givers plays an ever greater role. The study of Bonastre in
France [11] described the economic impact of AMD and
assessed its medical and non-medical costs out of the per-
spective of 105 French patients. In this study a significant
difference in the direct non-medical costs but not in the
direct medical costs between patients with wet AMD with
different visual acuity was found. The study of Javitt [16]
analysed the association between vision loss and higher
medical care costs of patients in the USA. In this context
it was found that a higher severity level of visual acuity
Table 3 Multivariate ANCOVA of direct total costs, quality of life and caring times
Direct total costs p-value Caregivers QoL p-value Caregivers caring time p-value
Multivariate ANCOVA Multivariate ANCOVA Multivariate ANCOVA
Caring hours per week <0.001 Caring hours per week <0.001 Visual acuity <0.001
Health insurance <0.01 Patient age 0.13 Caregivers QoL <0.001
Patient age 0.02 Caregiver gender 0.32 Caregiver age 0.04
Visual acuity 0.23 Caregiver age 0.54 Patient age 0.40
Caregiver age 0.62 Visual acuity 0.64 Health insurance 0.41
Caregiver gender 0.77 Health insurance 0.79 Caregiver gender 0.80
The costs did increase through patients being privately insured (p < 0.01), a higher patient age (p = 0.02) and more caring hours per week (p < 0.001). Concerning
the quality of life of the caregivers, only the caring hours per week had a significant influence (p < 0.001). Caregivers caring times were associated with a lower
visual acuity (p < 0.001), a lower QoL (p < 0.001) and a higher caregiver age (p = 0.04). Significant data were printed in bold
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caused higher medical costs. In addition to the men-
tioned costs of patients with vision loss, there are also
interesting findings concerning costs of informal care-
givers. For example the study undertaken by Schmier
et al. in the USA [17] investigated the impact of visual
impairment on use of caregiving by individuals with
AMD, whereby 803 respondents were interviewed. It
observed a tendency of increased caregiver time costs
simply with increased vision loss, which was also con-
firmed by our research (p = 0.002). The study of Straw-
bridge in the USA [18] assessd the impact of older
spouses’ vision impairment on the health and well-being
of their partners and tested gender differences on 418
older couples. It encountered a higher psychological
stress level for female caregivers. We were unable to
discern a significant difference in the QoL when looking
at the caregivers’ gender (p = 0.32), even though the
female caregivers had a slightly lower QoL on average.
Due to the recent literature on caregivers, we could as-
sume that caregivers have high costs and a low Quality
of Life when caring for a patient with wet AMD. How-
ever, the actual burden of the caregivers in this sample
is relatively small and lower than expected. We could
verify a rising financial burden and a lower QoL, which
was associated with increasing caring hours. However,
the total amount of direct medical and non-medical cost
of – on average – € 134 and € 405 per year respectively,
is lower than in the previous findings. In our study, no
further significant differences in QoL or direct medical
and non-medical costs among the three visual acuity
groups could be proved. It was particularly surprising
that the caregiver income had no influence on the care-
giver cost burden but rather the insurance of the pa-
tients. Even though the group size of publicly and
privately insured patients in this study was not the
same, it was significant that privately insured patients
caused a higher cost burden for caregivers. The fact that
the cost burden achieved a twice and almost six times
higher amount in the same visual acuity-group was not
expected.
In this study a high number of informal caregivers and
different new findings have been achieved. The limita-
tion can be seen in the missing comparison group and
in the fact, that the caregivers were interviewed only once
which makes it difficult to remember the incurred costs of
the different time periods. Concerning the fact, if the pa-
tient is statutory or privately insured, it is not possible to
transfer the findings to other European countries, because
of the different reimbursements of costs.
Conclusions
In conclusion, our study demonstrated that caregivers of
patients with wet AMD have a relatively low financial
burden compared to the previous findings. Espesially the
fact that the financial burden was mainly associated with
the privately insured patients and not with the visual
acuity, showed a new perspective concerning the health
equity context for patients with wet AMD. From the
point of view of helath policy in Germany, the results of
this study should be taken into account since the higher
costs of caregivers of privately insured patients were es-
pecially caused by medical aids. It is therefore necessary
to question the quality of patient care with medical aids
of statutory insured patients. Furthermore the patient
care concerning the personal services and rides to the
medical treatments musst be covered by the health in-
surance, since the caring hours per week had a signifi-
cant negative impact on the caregivers` QoL.
Table 4 Total direct and direct medical costs per year in € of caregivers of privately or statutory insured patients










>0.3 Statutory 72 Direct medical costs 72 93 0 236 0 1,266
Direct total costs 72 324 106 628 0 4,370
Private 20 Direct medical costs 20 79 28 132 0 480
Direct total costs 20 651 260 1,407 0 6,444
≤0.3 - >0.1 Statutory 23 Direct medical costs 23 60 3 141 0 666
Direct total costs 23 242 186 295 0 1,374
Private 3 Direct medical costs 3 80 6 133 0 233
Direct total costs 3 217 186 110 126 339
≤0.1 Statutory 27 Direct medical costs 27 140 27 280 0 1,094
Direct total costs 27 672 202 1,306 10 6,658
Private 5 Direct medical costs 5 1,258 1,367 921 265 2,529
Direct total costs 5 4,024 4,152 3,853 358 9,886
Caregivers of privately insured patients had more costs (p = 0.04). Despite the same visual acuity of ≤0.1 the caregiver costs of privately insured patients were six
times higher, than the caregiver costs of patients with public health insurance, seen in the mean score or 20 times higher seen in the median
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Fig. 4 Direct medical costs of caregivers of state (GKV) and privately (PKV) insured patients
Appendix 1
Fig. 5 Total direct costs of caregivers of state (GKV) and privately (PKV) insured patients
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Mean SD Mean SD Mean SD Mean SD
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Direct medical costs (€/year) 133 336 90 217 62 138 314 588
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The values are divided in the total sample and the three different visual acuities. It becomes clear that total direct costs, direct medical and direct non-medical
cost increase with a lower visual acuity apart from the visual acuity >0.3 to the visual acuity ≤0.3 - >0.1. Concerning the intangible costs of the different caregivers,
it gets clear, that there is no significant strain difference
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